{"id":235124,"date":"2026-09-08T13:36:51","date_gmt":"2026-09-08T08:06:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=235124"},"modified":"2026-09-08T13:36:52","modified_gmt":"2026-09-08T08:06:52","slug":"bafna-pharmaceuticals-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bafna-pharmaceuticals-share-price-buy-hold-or-sell\/","title":{"rendered":"Bafna Pharmaceuticals: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"

Bafna Pharmaceuticals share price Rs 307.75 (NSE), up nearly 2% today, near its 52-week high. 52-week range Rs 94.77 to Rs 318.50. Current-quarter data was not consistently available.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bafna Pharmaceuticals Ltd share price is trading around Rs 308, up nearly 2 percent today, close to its 52-week high of Rs 318.50 and more than triple its 52-week low of Rs 94.77. Despite this dramatic stock price appreciation over the past year, current-quarter and recent annual financial data was not consistently available across public sources at the time of writing, with the most recently confirmed disclosures dating back several years. The stock trades at a rich 91.95 times earnings against the pharmaceutical sector average near 50.8 times based on available trailing data, though this figure should be read with real caution given the significant data gap between the confirmed financials and the current dramatic price level.<\/p>\n<\/div>\n

Bafna Pharmaceuticals share price is up nearly 2 percent today, trading around Rs 308 on the NSE, close to its 52-week high of Rs 318.50, more than triple its 52-week low of Rs 94.77. Given the very significant gap between this dramatic price appreciation and the limited current financial data available, this article presents what is known plainly before laying out a careful, cautious view.<\/p>\n

This Bafna Pharmaceuticals overview walks through the available valuation data, the significant data limitations relative to the dramatic price move, and the technical setup, using figures sourced from public filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n